Vir Biotechnology, Inc.: capex
| Value | {"amount": 55432000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-09-30 |
| Status | current |
| Entity | Vir Biotechnology, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:28:03.755260+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/682913c0-0fb3-4495-92b0-102fb520e954
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-22-021854Retrieved: 2026-08-19T17:28:03.755260+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001706431/capex/2022-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/682913c0-0fb3-4495-92b0-102fb520e954
History
- no predecessors — first report